trial

Evaluating a Novel Mobile App for Social Cognition in Psychosis

NCTId NCT04260763
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 14 (actual)
Sponsored by King's College London
Primary completion 2019-04-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
14 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2018-08-30
Primary completion
2019-04-08
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Social Cognition GroupNovel Mobile App

Sponsors

King's College LondonLead Sponsor

Investigators

1
Matteo Cella, DClinPsyPrincipal Investigator

Sites

1 total
London, United Kingdom

Facts & assertions

4 sourced
Enrollment
14
Phase
NA
Primary Completion Date
2019-04-08
Status
COMPLETED
relationships
The graph out of here
drug
Social Cognition Group
drug
Novel Mobile App
drug
lead_sponsor
King's College London
company
indication
Schizophrenia; Psychosis
indication
Schizophrenia
indication
Psychotic Disorders
indication
investigator
Matteo Cella, DClinPsy
person